Lina Ljung1, Bertil Lindahl2, Kai M Eggers3, Mats Frick4, Rikard Linder5, Henrik B Löfmark5, Arne Martinsson6, Dina Melki7, Nondita Sarkar8, Per Svensson9, Tomas Jernberg5. 1. Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Stockholm, Sweden; Department of Cardiology, Södersjukhuset, Stockholm, Sweden. Electronic address: lina.ljung@sll.se. 2. Department of Medical Sciences, Uppsala University, Uppsala, Sweden; Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden. 3. Department of Medical Sciences, Uppsala University, Uppsala, Sweden. 4. Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Stockholm, Sweden; Department of Cardiology, Södersjukhuset, Stockholm, Sweden. 5. Department of Clinical Sciences, Danderyd University Hospital, Karolinska Institutet, Stockholm, Sweden. 6. Department of Emergency Medicine, Capio St Göran's Hospital, Stockholm, Sweden. 7. Heart and Vascular Theme, Karolinska University Hospital, Stockholm, Sweden. 8. Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden; Heart and Vascular Theme, Karolinska University Hospital, Stockholm, Sweden. 9. Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden; Functional Area of Emergency Medicine, Karolinska University Hospital Solna, Stockholm, Sweden.
Abstract
STUDY OBJECTIVE: We evaluate whether a combination of a 1-hour high-sensitivity cardiac troponin algorithm and History, ECG, Age, Risk Factors, and Troponin (HEART) score reduces admission rate (primary outcome) and affects time to discharge, health care-related costs, and 30-day outcome (secondary outcomes) in patients with symptoms suggestive of an acute coronary syndrome. METHODS: This prospective observational multicenter study was conducted before (2013 to 2014) and after (2015 to 2016) implementation of a strategy including level of high-sensitivity cardiac troponin T or I at 0 and 1 hour, combined with the HEART score. Patients with a nonelevated baseline high-sensitivity cardiac troponin level, a 1-hour change in high-sensitivity cardiac troponin T level less than 3 ng/L, or high-sensitivity cardiac troponin I level less than 6 ng/L and a HEART score less than or equal to 3 were considered to be ruled out of having acute coronary syndrome. A logistic regression analysis was performed to adjust for differences in baseline characteristics. RESULTS: A total of 1,233 patients were included at 6 centers. There were no differences in regard to median age (64 versus 63 years) and proportion of men (57% versus 54%) between the periods. After introduction of the new strategy, the admission rate decreased from 59% to 33% (risk ratio 0.55 [95% confidence interval {CI} 0.48 to 0.63]; odds ratio 0.33 [95% CI 0.26 to 0.42]; adjusted odds ratio 0.33 [95% CI 0.25 to 0.42]). The median hospital stay was reduced from 23.2 to 4.7 hours (95% CI of difference -20.4 to -11.4); median health care-related costs, from $1,748 to $1,079 (95% CI of difference -$953 to -$391). The number of clinical events was very low. CONCLUSION: In this before-after study, clinical implementation of a 1-hour high-sensitivity cardiac troponin algorithm combined with the HEART score was associated with a reduction in admission rate and health care burden, with very low rates of adverse clinical events.
STUDY OBJECTIVE: We evaluate whether a combination of a 1-hour high-sensitivity cardiac troponin algorithm and History, ECG, Age, Risk Factors, and Troponin (HEART) score reduces admission rate (primary outcome) and affects time to discharge, health care-related costs, and 30-day outcome (secondary outcomes) in patients with symptoms suggestive of an acute coronary syndrome. METHODS: This prospective observational multicenter study was conducted before (2013 to 2014) and after (2015 to 2016) implementation of a strategy including level of high-sensitivity cardiac troponin T or I at 0 and 1 hour, combined with the HEART score. Patients with a nonelevated baseline high-sensitivity cardiac troponin level, a 1-hour change in high-sensitivity cardiac troponin T level less than 3 ng/L, or high-sensitivity cardiac troponin I level less than 6 ng/L and a HEART score less than or equal to 3 were considered to be ruled out of having acute coronary syndrome. A logistic regression analysis was performed to adjust for differences in baseline characteristics. RESULTS: A total of 1,233 patients were included at 6 centers. There were no differences in regard to median age (64 versus 63 years) and proportion of men (57% versus 54%) between the periods. After introduction of the new strategy, the admission rate decreased from 59% to 33% (risk ratio 0.55 [95% confidence interval {CI} 0.48 to 0.63]; odds ratio 0.33 [95% CI 0.26 to 0.42]; adjusted odds ratio 0.33 [95% CI 0.25 to 0.42]). The median hospital stay was reduced from 23.2 to 4.7 hours (95% CI of difference -20.4 to -11.4); median health care-related costs, from $1,748 to $1,079 (95% CI of difference -$953 to -$391). The number of clinical events was very low. CONCLUSION: In this before-after study, clinical implementation of a 1-hour high-sensitivity cardiac troponin algorithm combined with the HEART score was associated with a reduction in admission rate and health care burden, with very low rates of adverse clinical events.
Authors: Tonje R Johannessen; Sigrun Halvorsen; Dan Atar; John Munkhaugen; Anne Kathrine Nore; Torbjørn Wisløff; Odd Martin Vallersnes Journal: BMC Health Serv Res Date: 2022-10-21 Impact factor: 2.908
Authors: Edward Hyun Suh; Aleksandr M Tichter; Lauren S Ranard; Andrew Amaranto; Betty C Chang; Phong Anh Huynh; Alexander Kratz; Rebekah Jihae Lee; LeRoy E Rabbani; Dana Sacco; Andrew J Einstein Journal: J Am Coll Emerg Physicians Open Date: 2022-05-05
Authors: Salena M Preciado; Adam L Sharp; Benjamin C Sun; Aileen Baecker; Yi-Lin Wu; Ming-Sum Lee; Ernest Shen; Maros Ferencik; Shaw Natsui; Aniket A Kawatkar; Stacy J Park; Rita F Redberg Journal: Ann Emerg Med Date: 2021-01-06 Impact factor: 5.721
Authors: Atul Anand; Kuan Ken Lee; Andrew R Chapman; Amy V Ferry; Phil D Adamson; Fiona E Strachan; Colin Berry; Iain Findlay; Anne Cruikshank; Alan Reid; Paul O Collinson; Fred S Apple; David A McAllister; Donogh Maguire; Keith A A Fox; David E Newby; Chris Tuck; Ronald Harkess; Catriona Keerie; Christopher J Weir; Richard A Parker; Alasdair Gray; Anoop S V Shah; Nicholas L Mills Journal: Circulation Date: 2021-03-23 Impact factor: 39.918
Authors: Rebecca Vigen; Deborah B Diercks; Ibrahim A Hashim; Ambarish Pandey; Lin Zhong; Patricia Kutscher; Fernabelle Fernandez; Amy Yu; Bryan Bertulfo; Kyle Molberg; Jeffery C Metzger; Jose Soto; Dergham Alzubaidy; Lorie Thibodeaux; Jose A Joglar; Sandeep R Das; James A de Lemos Journal: JAMA Netw Open Date: 2020-04-01
Authors: Dennis Sandeman; Maaz B J Syed; Dorien M Kimenai; Kuan Ken Lee; Atul Anand; Shruti S Joshi; Lorraine Dinnel; Philip R Wenham; Ken Campbell; Mary Jarvie; Donna Galloway; Mhairi Anderson; Bappa Roy; Jack P M Andrews; Fiona E Strachan; Amy V Ferry; Andrew R Chapman; Sarah Elsby; Mark Francis; Robert Cargill; Anoop S V Shah; Nicholas L Mills Journal: Open Heart Date: 2021-11